CNSP
Price
$0.92
Change
-$0.02 (-2.13%)
Updated
Jul 3 closing price
Capitalization
5.02M
MGNX
Price
$1.46
Change
+$0.08 (+5.80%)
Updated
Jul 3 closing price
Capitalization
92.11M
39 days until earnings call
Interact to see
Advertisement

CNSP vs MGNX

Header iconCNSP vs MGNX Comparison
Open Charts CNSP vs MGNXBanner chart's image
CNS Pharmaceuticals
Price$0.92
Change-$0.02 (-2.13%)
Volume$71.08K
Capitalization5.02M
MacroGenics
Price$1.46
Change+$0.08 (+5.80%)
Volume$699.98K
Capitalization92.11M
CNSP vs MGNX Comparison Chart in %
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNSP vs. MGNX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and MGNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CNSP: $0.92 vs. MGNX: $1.46)
Brand notoriety: CNSP and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 3% vs. MGNX: 51%
Market capitalization -- CNSP: $5.02M vs. MGNX: $92.11M
CNSP [@Biotechnology] is valued at $5.02M. MGNX’s [@Biotechnology] market capitalization is $92.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • CNSP’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CNSP is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 4 TA indicator(s) are bullish while MGNX’s TA Score has 5 bullish TA indicator(s).

  • CNSP’s TA Score: 4 bullish, 4 bearish.
  • MGNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CNSP and MGNX are a good buy in the short-term.

Price Growth

CNSP (@Biotechnology) experienced а +9.92% price change this week, while MGNX (@Biotechnology) price change was +14.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CNSP is expected to report earnings on May 15, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($92.1M) has a higher market cap than CNSP($5.03M). MGNX YTD gains are higher at: -55.077 vs. CNSP (-84.718). CNSP has higher annual earnings (EBITDA): -15.6M vs. MGNX (-47.33M). MGNX has more cash in the bank: 154M vs. CNSP (13M). CNSP has less debt than MGNX: CNSP (211K) vs MGNX (37.5M). MGNX has higher revenues than CNSP: MGNX (152M) vs CNSP (0).
CNSPMGNXCNSP / MGNX
Capitalization5.03M92.1M5%
EBITDA-15.6M-47.33M33%
Gain YTD-84.718-55.077154%
P/E Ratio0.00N/A-
Revenue0152M-
Total Cash13M154M8%
Total Debt211K37.5M1%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNSPMGNX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABVX7.960.20
+2.58%
Abivax SA
ASGN52.840.64
+1.23%
ASGN
RGA197.791.70
+0.87%
Reinsurance Group of America
RR1.96-0.05
-2.49%
Richtech Robotics
VERO2.57-0.38
-12.88%
Venus Concept

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with VIR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-2.12%
VIR - CNSP
36%
Loosely correlated
-0.37%
AAVXF - CNSP
34%
Loosely correlated
N/A
PTGX - CNSP
30%
Poorly correlated
+0.71%
MGNX - CNSP
27%
Poorly correlated
+5.80%
NRIX - CNSP
26%
Poorly correlated
+2.33%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+5.80%
CRBU - MGNX
51%
Loosely correlated
N/A
XNCR - MGNX
50%
Loosely correlated
+1.45%
BEAM - MGNX
47%
Loosely correlated
+0.65%
SYRE - MGNX
46%
Loosely correlated
+1.68%
RGNX - MGNX
46%
Loosely correlated
+1.39%
More